Pioglitazone and thyroid cancer risk in Taiwanese patients with type 2 diabetes 台湾2型糖尿病患者使用吡格列酮与甲状腺癌风险

This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.

If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.